THEOLYTICS
Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
THEOLYTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2017-12-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.theolytics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Microsoft Azure DNS Google Google Cloud
Similar Organizations
Agathos Biologics
Agathos Biologics is a biotechnology company developing transformational science within a strong ethical and moral framework.
AI4R
AI4R engages in digital real-time autoradiography, a new-generation imaging solutions for preclinical studies.
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Apoglyx
Apoglyx is a pre-clinical stage virtual biotech company with the aim to develop an oral therapy for type 2 diabetes patients.
Carcell Biopharma
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
Curevo
Curevo is a clinical-stage biotech firm focused on producing next-generation vaccines.
Engimmune Therapeutics
Engimmune Therapeutics is a platform and product development company engineering next-generation T cell receptor therapies.
eureKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
FimmCyte
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
GeneMedicine
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
HEPHAISTOS-Pharma
HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies.
Innatera Nanosystems
Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
Innoskel
InnoSkel is a pioneering platform biotechnology company developing therapies for rare skeletal diseases.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Mediar Therapeutics
Mediar is a preclinical stage biotechnology company developing therapeutics to halt, or even reverse, fibrosis.
NAVAN Technologies
NAVAN Technologies is a privately-held biotechnology company enabling the development of next generation cell and gene therapies
Olgram
Olgram is a biotechnology company that develops marine molecules for the prevention and control of chronic bacterial infections.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Opal Biosciences
Opal Biosciences is a preclinical-stage biotechnology company specializing in treating infectious diseases.
PamBio
PamBio is a pre-clinical stage biotechnology company developing drug therapy for acute bleeding conditions.
PEP-Therapy
Innovative peptides as targeted therapies for oncology
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Rhovac ApS
RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells.
Saftra Photonics
Saftra Photonics is a Slovak high-tech company established as a spin-off from the P. J. Safarik University, Kosice, Slovakia in 2014.
TandemAI
TandemAI is an advanced technology company dedicated to reinventing drug discovery infrastructure.
Unibio International
Unibio is operating in the biotechnology sector with core competences within bacterial fermentation.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oxford Science Enterprises
Oxford Science Enterprises investment in Series A - Theolytics
Epidarex Capital
Epidarex Capital investment in Series A - Theolytics
Taiho Ventures
Taiho Ventures investment in Series A - Theolytics
M Ventures
M Ventures investment in Series A - Theolytics
Oxford Science Enterprises
Oxford Science Enterprises investment in Seed Round - Theolytics
Official Site Inspections
http://www.theolytics.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.29 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
